The document is an intimation of an Analyst/Investor Conference Call arranged pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The event is scheduled for Monday, 16th November, 2026 from 15:00 hrs to 16:00 hrs IST.
The stated purpose is to discuss the financial result and performance of the Company for the quarter and half year ended on 30th September, 2026 (Q2 FY27).
The meeting is scheduled after the earnings announcement, as the company will announce its Q2FY27 results on 13th November, 2026.
Management participants will include Mr. Harshil Dalal (Global CFO) and Mr. Stephan Fritschi (Chief Executive Officer, Carbogen Amcis Entities).
The document includes detailed dial-in information but does not explicitly mention whether a presentation, earnings deck, transcript, or recording will be made available.
The document contains standard compliance language as a regulatory filing but does not include an explicit statement regarding unpublished price sensitive information (UPSI).
Additional Notes Section
The document includes an attachment with conference call details (dial-in numbers, pre-registration link).
No financial data or performance figures were disclosed in this announcement.
Contact details for investor relations (Harshil Dalal) and external representative (Krishna Patel of Ernst & Young LLP) are provided for follow-up.
The company profile describes Dishman Carbogen Amcis Limited as a fully integrated Contract Development and Manufacturing Organisation (CDMO) established in 1983 with global presence in Switzerland, UK, France, Netherlands, India, and China.
